{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:50:45Z","timestamp":1793044245890,"version":"4.5.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Metaplastic breast carcinoma (MBC) with squamous differentiation can often be diagnosed by routine histopathologic evaluation, but cutaneous squamous cell carcinoma (cSCC) may enter the differential diagnosis in selected pure squamous carcinomas involving the breast\/chest, particularly in limited samples or cases lacking definitive epidermal connection, ductal carcinoma in situ, or complete clinical information. Determining the site of origin is clinically important because management strategies for breast and cutaneous carcinomas differ substantially. We sought to identify immunohistochemical and genetic features that could distinguish MBC with squamous differentiation from cSCC arising in breast\/chest skin in cases of uncertain origin. To this end, we comprehensively characterized 15 MBC with pure to mixed squamous differentiation and 18 invasive\/in situ cSCC arising in breast\/chest skin. Comparisons between these cohorts and 48 SCC of other anatomic sites identified significant immunohistochemical differences, with CK7, SOX10, and TRPS1 expression more frequent in MBC than cSCC (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0005, 0.0227, and 0.0290, respectively). HER2 overexpression was identified only in breast and esophageal carcinomas. Next-generation sequencing of the breast\/chest tumors demonstrated more frequent\n                    <jats:italic toggle=\"yes\">PIK3CA\/PIK3R1<\/jats:italic>\n                    alterations in MBC than cSCC (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0040), whereas\n                    <jats:italic toggle=\"yes\">NOTCH1<\/jats:italic>\n                    mutations were exclusive to cSCC (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0407). cSCC showed higher tumor mutational burden and percentage of ultraviolet-associated mutations than MBC (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0002 and &lt;0.0001, respectively). These distinguishing features were then applied to 9 additional breast cases of uncertain origin, demonstrating the added value of molecular data in diagnostically challenging cases. Overall, these findings support a stepwise diagnostic approach integrating immunohistochemistry, selected molecular features, and clinicopathologic context to aid in this distinction.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002601","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:00:07Z","timestamp":1788336007000},"page":"1372-1387","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Immunohistochemical and Molecular Features Distinguishing Metaplastic Breast Carcinoma With Squamous Differentiation From Cutaneous Squamous Cell Carcinoma"],"prefix":"10.1097","volume":"50","author":[{"given":"Cooper D.","family":"Rutland","sequence":"first","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra G.","family":"Kingsley","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Zdravkovic","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Vohra","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[{"name":"Department of Pathology, Diagnostics Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-8283","authenticated-orcid":false,"given":"Gregory R.","family":"Bean","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"R2-20261014","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/cup.12766","article-title":"Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review","volume":"43","author":"Cheng","year":"2016","journal-title":"J Cutan Pathol"},{"key":"R3-20261014","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/PAS.0000000000001824","article-title":"TRPS1 expression in breast carcinomas: focusing on metaplastic breast carcinomas","volume":"46","author":"Parkinson","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R4-20261014","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/DAD.0000000000000306","article-title":"GATA3 expression in normal skin and in benign and malignant epidermal and cutaneous adnexal neoplasms","volume":"37","author":"Mertens","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R5-20261014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4132\/jptm.2024.01.23","article-title":"TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases","volume":"58","author":"Liu","year":"2024","journal-title":"J Pathol Transl Med"},{"key":"R6-20261014","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/cup.14523","article-title":"Transcriptional repressor GATA binding 1 (TRPS1) immunoexpression in normal skin tissues and various cutaneous tumors","volume":"50","author":"Taniguchi","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R7-20261014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jclinpath-2020-206468","article-title":"Clinicopathologic characteristics of HER2-positive metaplastic squamous cell carcinoma of the breast","volume":"75","author":"Lei","year":"2022","journal-title":"J Clin Pathol"},{"key":"R8-20261014","doi-asserted-by":"crossref","first-page":"e941448","DOI":"10.12659\/AJCR.941448","article-title":"A case report of a rare ER+, PR- pure metaplastic breast squamous cell carcinoma with HER2 overexpression","volume":"24","author":"Adam","year":"2023","journal-title":"Am J Case Rep"},{"key":"R9-20261014","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/1078-0432.CCR-16-2857","article-title":"The landscape of somatic genetic alterations in metaplastic breast carcinomas","volume":"23","author":"Ng","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R10-20261014","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clbc.2016.07.004","article-title":"Metaplastic breast cancer: molecular typing and identification of potential targeted therapies at a single institution","volume":"17","author":"Edenfield","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"R11-20261014","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/path.5184","article-title":"Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications","volume":"247","author":"McCart Reed","year":"2019","journal-title":"J Pathol"},{"key":"R12-20261014","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3390\/cancers12071832","article-title":"Molecular features of metaplastic breast carcinoma: an infrequent subtype of triple negative breast carcinoma","volume":"12","author":"Gonz\u00e1lez-Mart\u00ednez","year":"2020","journal-title":"Cancers"},{"key":"R13-20261014","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41379-018-0081-z","article-title":"Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma","volume":"31","author":"Krings","year":"2018","journal-title":"Mod Pathol"},{"key":"R14-20261014","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat Commun"},{"key":"R15-20261014","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/exd.14730","article-title":"Targeted deep sequencing reveals genomic alterations of actinic keratosis\/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma","volume":"32","author":"Kim","year":"2023","journal-title":"Exp Dermatol"},{"key":"R16-20261014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/php.12377","article-title":"UV signature mutations","volume":"91","author":"Brash","year":"2015","journal-title":"Photochem Photobiol"},{"key":"R17-20261014","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.88.22.10124","article-title":"A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma","volume":"88","author":"Brash","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-20261014","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"key":"R19-20261014","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"R20-20261014","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jmoldx.2017.10.007","article-title":"Comprehensive genomic profiling of malignant effusions in patients with metastatic lung adenocarcinoma","volume":"20","author":"Yang","year":"2018","journal-title":"J Mol Diagn"},{"key":"R21-20261014","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41379-020-0511-6","article-title":"Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis","volume":"33","author":"Beca","year":"2020","journal-title":"Mod Pathol"},{"key":"R22-20261014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12105-024-01620-x","article-title":"Utility of UV signature mutations in the diagnostic assessment of metastatic head and neck carcinomas of unknown primary","volume":"18","author":"Furlan","year":"2024","journal-title":"Head Neck Pathol"},{"key":"R23-20261014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.humpath.2018.11.023","article-title":"Molecular characterization of metaplastic breast carcinoma via next-generation sequencing","volume":"86","author":"Zhai","year":"2019","journal-title":"Hum Pathol"},{"key":"R24-20261014","doi-asserted-by":"crossref","first-page":"e70188","DOI":"10.1111\/apm.70188","article-title":"Deciphering morphological spectrum, stemness and PI3K\/AKT\/PTEN\/MAPK pathway alterations in metaplastic breast carcinoma","volume":"134","author":"Shashidhar Chittapragada","year":"2026","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"R25-20261014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12672-024-00950-0","article-title":"Immunohistochemical and molecular profiles of heterogeneous components of metaplastic breast cancer: a squamous cell carcinomatous component was distinct from a spindle cell carcinomatous component","volume":"15","author":"Suzuki","year":"2024","journal-title":"Discov Oncol"},{"key":"R26-20261014","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/hed.24765","article-title":"Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: a search for prognostic markers and therapeutic targets","volume":"39","author":"Ashford","year":"2017","journal-title":"Head Neck"},{"key":"R27-20261014","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","article-title":"Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"R28-20261014","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cancers18040558","article-title":"Genomic insights into cutaneous squamous cell carcinoma","volume":"18","author":"Saglimbeni","year":"2026","journal-title":"Cancers"},{"key":"R29-20261014","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1038\/s41467-025-65687-y","article-title":"Genetic evolution of keratinocytes to cutaneous squamous cell carcinoma","volume":"16","author":"Tandukar","year":"2025","journal-title":"Nat Commun"},{"key":"R30-20261014","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational landscape of aggressive cutaneous squamous cell carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R31-20261014","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/1878-0261.12813","article-title":"The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas","volume":"15","author":"Moukarzel","year":"2021","journal-title":"Mol Oncol"},{"key":"R32-20261014","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41467-020-15283-z","article-title":"Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors","volume":"11","author":"Djomehri","year":"2020","journal-title":"Nat Commun"},{"key":"R33-20261014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5582\/irdr.2023.01069","article-title":"PIK3CA mutations in cutaneous squamous cell carcinoma","volume":"12","author":"Kusaba","year":"2023","journal-title":"Intractable Rare Dis Res"},{"key":"R34-20261014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies","volume":"122","author":"Al-Rohil","year":"2016","journal-title":"Cancer"},{"key":"R35-20261014","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R36-20261014","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/path.5091","article-title":"CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer","volume":"245","author":"Bartels","year":"2018","journal-title":"J Pathol"},{"key":"R37-20261014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41523-021-00250-8","article-title":"TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer","volume":"7","author":"da Silva","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"R38-20261014","doi-asserted-by":"crossref","first-page":"R1028","DOI":"10.1186\/bcr1341","article-title":"Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis","volume":"7","author":"Reis-Filho","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R39-20261014","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41379-019-0208-x","article-title":"Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy","volume":"32","author":"Han","year":"2019","journal-title":"Mod Pathol"},{"key":"R40-20261014","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1634\/theoncologist.2017-0398","article-title":"Early and locally advanced metaplastic breast cancer: presentation and survival by receptor status in surveillance, epidemiology, and end results (SEER) 2010-2014","volume":"23","author":"Schroeder","year":"2018","journal-title":"Oncologist"},{"key":"R41-20261014","first-page":"843","article-title":"Clinicopathological features and HER2 expression of metaplastic squamous cell carcinoma of the breast","volume":"51","author":"Gao","year":"2022","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"R42-20261014","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/PAI.0000000000001313","article-title":"TRPS1 expression across the spectrum of Paget disease and morphologic mimics","volume":"34","author":"Rutland","year":"2026","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R43-20261014","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1600-0560.2010.01562.x","article-title":"CK7 expression in primary cutaneous squamous cell carcinoma","volume":"37","author":"Pulitzer","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R44-20261014","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.2147\/CMAR.S250867","article-title":"SOX10\u2014a novel marker for the differential diagnosis of breast metaplastic squamous cell carcinoma","volume":"12","author":"Qi","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R45-20261014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cup.12667","article-title":"Cutaneous squamous cell carcinoma progression is associated with decreased GATA-3 immunohistochemical staining","volume":"43","author":"Solus","year":"2016","journal-title":"J Cutan Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:00:14Z","timestamp":1791961214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002601","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"2026-05-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}